This page shows the latest Neurodegenerative disease news and features for those working in and with pharma, biotech and healthcare.
Merck &Co has signed a strategic collaboration agreement with Amathus Therapeutics focused on developing novel small molecule candidates for neurodegenerative diseases. ... The Merck neuroscience team is an ideal partner to translate this novel approach
CALD is a progressive and fatal neurodegenerative disease that overwhelmingly affects males. ... On the safety front, bluebird bio also said that no events of acute or chronic graft-versus-host disease (GvHD) have been reported following treatment with
The company is developing PINK1 targeted therapies for the treatment of neurodegenerative and mitochondrial diseases. ... If AbbVie does exercise its option to license Mitokinin’s PINK1 asset, it will add a new candidate to its neurodegenerative
Companies will co-develop molecules for the treatment of immunological and neurodegenerative diseases. ... The ethos behind RIPK1 inhibitor development is to offer a new kind of approach towards treating a range of autoimmune, inflammatory and
Study will evaluate oral semaglutide in neurodegenerative disease. Novo Nordisk is planning to enter a late-stage development programme with the launch of a phase 3a study of oral semaglutide in ... Alzheimer’s disease has been an area of extensive
Handl Therapeutics – based in Leuven, Belgium – specialises in adeno-associated virus (AAV) capsid technology and has a focus on developing disease modifying gene therapies to treat neurodegenerative diseases. ... The Lacerta deal is focused on
More from news
Approximately 2 fully matching, plus 69 partially matching documents found.
A disease pathway – a chain of signals between molecules that trigger different cell functions – may involve thousands of interacting proteins. ... The project is initially connecting four of London’s premier teaching hospitals, offering AI
Yet the effort to find different ways to combat the neurodegenerative disease have not stalled, with researchers looking into the possibility of early detection as a new avenue to explore in ... According to the study, the blood test is able to identify
Nevertheless, strategies for developing successful therapeutic interventions are shifting. We have developed a five-point roadmap to successful treatments for Alzheimer’s disease and neurodegenerative diseases. ... Hyper-stimulation of microglial cells
The design of such neuroprotective studies may benefit from the lessons learned in studies in the most common neurodegenerative disease, Alzheimer’s. ... Target early disease stages: It is probably true for all neurodegenerative diseases that symptoms
During the option, AZ will continue to research and evaluate OX CLI in respiratory disease (see table 2). ... SMA is an orphan neurodegenerative genetic disease that presents early in life.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Most recently, Grant was chief executive officer of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease.
Francois Nader joins the biotech. Prevail Therapeutics, a biotechnology company focused on the development of gene therapies for patients with neurodegenerative diseases, has strengthened its board of directors with the addition ... The Prevail team has
Novartis’ Michael Ryan joins the neurodegenerative diseases specialist. Lausanne, Switzerland-based Asceneuron has appointed Michael Ryan as its new chief medical officer. ... His outstanding track record and expertise in neurodegenerative disease are
As global lead for Alzheimer's Disease she will also be tasked with developing strategies and heading internal and external collaborations. . ... Eisai's Cheung said: "With her deep expertise in the commercial development of in-line and
The US-based pharmaceutical firm specialises in developing disease-modifying treatments for neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS). ... Loeb University Professor Emeritus at Harvard University. He said: “Amylyx has
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). ... ALS is a progressive neurodegenerative disease, and the fast onset of increasingly severe symptoms after diagnosis can be devastating.
The case against cannibalism began with an earlier medical discovery. A neurodegenerative disease known as kuru was found to be common among the Fore people of Papua New Guinea. ... This was later identified as a prion (misfolded protein), and therefore
The challenge:. Our client was developing a portfolio for the treatment of a chronic neurodegenerative disease and planned to have a significant presence at key neuroscience conferences over the coming year.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...